(Q42999904)

12 November 2017

title

Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines (English)

1 reference

12 November 2017

0 references

4

1 reference

12 November 2017

Rafik Fayzulin

1

1 reference

12 November 2017

Frank Scholle

series ordinal

2

1 reference

12 November 2017

Olga Petrakova

series ordinal

3

1 reference

12 November 2017

Peter W Mason

series ordinal

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

2 May 2006

1 reference

12 November 2017

1 reference

12 November 2017

volume

351

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

196-209

1 reference

Flavivirus genome organization, expression, and replication

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Fine Mapping of a cis-Acting Sequence Element in Yellow Fever Virus RNA That Is Required for RNA Replication and Cyclization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Incorporation of Tick-Borne Encephalitis Virus Replicons into Virus-Like Particles by a Packaging Cell Line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Identification of Distinct Antigenic Determinants on Dengue-2 Virus Using Monoclonal Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Tetracycline-inducible packaging cell line for production of flavivirus replicon particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Construction and applications of yellow fever virus replicons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Essential role of cyclization sequences in flavivirus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Functional Analysis of Mosquito-Borne Flavivirus Conserved Sequence Elements within 3' Untranslated Region of West Nile Virus by Use of a Reporting Replicon That Differentiates between Viral Translation and RNA Replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Development of Dengue virus type 2 replicons capable of prolonged expression in host cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

An infectious West Nile virus that expresses a GFP reporter gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Construction and characterization of subgenomic replicons of New York strain of West Nile virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.02.036

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.02.036

1 reference

12 November 2017

1 reference